CMS’ Legal Justification Of Gender Affirming Care Ban Could Place Other Medications At Risk

 
• By Sarah Karlin-Smith
  
CMS Administrator Oz
CMS Administrator Mehmet Oz spoke about new proposed rules to limit gender affirming care on Dec. 18 (HHS)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from United States